Alpha Capital Management’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$5.49M Sell
15,596
-28
-0.2% -$9.98K 0.8% 41
2025
Q4
$5.11M Buy
15,624
+32
+0.2% +$10.2K 0.72% 48
2025
Q3
$4.4M Buy
15,592
+555
+4% +$161K 0.7% 55
2025
Q2
$4.2M Buy
15,037
+504
+3% +$143K 0.72% 53
2025
Q1
$4.53M Buy
14,533
+376
+3% +$111K 0.86% 43
2024
Q4
$3.69M Buy
14,157
+623
+5% +$185K 0.68% 54
2024
Q3
$4.36M Buy
13,534
+129
+1% +$42.2K 0.82% 43
2024
Q2
$4.19M Buy
13,405
+298
+2% +$87.5K 0.82% 45
2024
Q1
$3.73M Buy
+13,107
New +$3.84M 0.73% 53

Other funds holding AMGN

Alpha Capital Management's AMGN Position: Q1 2026 in Review

Alpha Capital Management reduced its Amgen (AMGN) stake by 0.18% in Q1 2026, selling an estimated $9.98K and leaving 15,596 shares worth $5.49M. The position accounts for 0.8% of the portfolio, ranked #41.

Alpha Capital Management first reported a position in AMGN in Q1 2024 and has held it in 9 quarters since. 3,129 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • Alpha Capital Management held 15,596 shares of Amgen worth $5.49M as of Q1 2026.
  • Alpha Capital Management sold 28 Amgen shares in Q1 2026, an estimated $9.98K.
  • Amgen made up 0.8% of Alpha Capital Management's portfolio in Q1 2026, its #41 holding.
  • Alpha Capital Management first reported a position in Amgen in Q1 2024 and has held it in 9 quarters since.
  • 3,129 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Alpha Capital Management's 13F filing for Q1 2026, filed 13 May 2026.